BioSkepsis vs Elicit: Biomedical AI Research Assistant vs General-Purpose Systematic Review Tool

How Elicit's column-extraction workflow operates for systematic biomedical reviews

Elicit's flagship feature is a structured data pipeline that converts unstructured paper text into a comparable table. You define the columns — either from a preset library (sample size, intervention, effect size, limitations, population, study design) or by writing a custom field in plain English, such as "Did the study blind the assessors?" — and Elicit runs each column as a targeted extraction prompt against every paper in your set.

For each paper × column pair, the model locates the relevant passage, extracts or synthesises the answer, and returns both the extracted value and a verbatim quote with a source link. Results are assembled into a spreadsheet-style grid: papers as rows, your columns as columns. The guided search → screen → extract → report flow is PRISMA-compatible and purpose-built for meta-analysis preparation — the kind of work where reproducible extraction across 50–200 RCTs matters more than conversational depth on any single paper.

How BioSkepsis retrieves and reasons over biomedical literature

BioSkepsis retrieval is weighted by Gene Ontology terms, MeSH descriptors, gene symbols, and pathway relationships. A query about tumour-infiltrating lymphocyte density and immunotherapy response in triple-negative breast cancer returns papers linked by the biological concepts involved — TILs, TNBC, immune checkpoint inhibitors, PD-L1 expression — not just papers whose text happens to contain those strings. Elicit covers all disciplines and treats biomedical papers the same as education or economics papers.

Answers are grounded in full text including methods, controls, and supplementary data. Every claim links back to the exact passage in the retrieved paper. When evidence is insufficient, BioSkepsis declines to answer rather than generating a plausible-sounding response. The research landscape graph classifies papers by structural role — Foundational, Hub, Bridge, and Novel — and draws on Semantic Scholar's 200M+ corpus for landscape expansion beyond the curated biomedical index.

Feature comparison: BioSkepsis vs Elicit for biomedical research

Who should use which — by researcher type

When to choose which

Choose BioSkepsis if:

• You work in biology, medicine, pharma, biotech, or ag/vet/env science and need retrieval grounded in Gene Ontology, MeSH, and gene symbols — not just text similarity over a general corpus
• You are actively investigating a research question and want to reason conversationally over full-text literature
• You want to upload your own experimental notes or results and have them interpreted against published evidence with citations
• You want to map the citation network, identify foundational vs. novel papers, or detect emerging research frontiers
• You want ongoing free access rather than a monthly-capped credit pool

Choose Elicit if:

• You need structured data extraction across 50+ papers with custom columns (sample size, intervention, effect size, limitations)
• You are conducting a formal systematic review or meta-analysis with a reproducible extraction protocol
• You are reviewing literature across multiple disciplines — education, economics, policy, public health — that fall outside the biomedical domain
• You need access to clinical trials data (545K trials in Elicit's corpus)

Using both Elicit and BioSkepsis

The two tools cover different phases of the same project and work best in sequence rather than as substitutes.

You are a bench scientist who also publishes systematic reviews. Use BioSkepsis day-to-day to reason over the literature and stay current with your field, then switch to Elicit when a project reaches the formal evidence-synthesis stage and you need a reproducible extraction table.

You are scoping a review before committing to it. Start in BioSkepsis to explore the landscape, identify key paper clusters, spot emerging trends, and understand what the field looks like. Move to Elicit once you have a refined PICO question and a defined inclusion/exclusion set — and need to extract data at scale.

You are writing a grant that requires both hypothesis generation and evidence tables. BioSkepsis helps you build the scientific rationale and frame novel hypotheses grounded in full-text evidence. Elicit helps you populate the background evidence table with structured, comparable data across studies.

You are part of a lab team with mixed roles. Principal investigators and bench scientists work in BioSkepsis for day-to-day research intelligence; a systematic reviewer or research coordinator handles the structured extraction workflow in Elicit. Both tools sync references to Zotero, so outputs stay in the same library.

Your review spans biology and non-biomedical disciplines. BioSkepsis surfaces the life-science literature with biological precision; Elicit covers the social science, health policy, or economics literature that a biomedical-focused corpus does not index. Running both searches and merging results in Zotero gives the most complete evidence base.

Free tier availability for biomedical and academic research

Both tools offer a free tier. We deliberately do not print dollar amounts here because vendor pricing changes — always verify on the live pricing page.

BioSkepsis — free tier: yes. Basic includes semantic search across 40M+ biomedical papers, the research landscape graph, and hypothesis and methodology generation, capped at 100 papers per session. Ongoing, no time limit, no credit card required. BioSkepsis pricing →

Elicit — free tier: yes (capped). Time-limited credits and capped reports per month. See the vendor page for current terms. Elicit pricing →

Frequently asked questions